FXG: Resp (Asp+) is a diagnostic product that provides clinicians with reliable and accurate results for two of the most common fungal diseases in less than half a day, enabling them to make faster decisions and to potentially start treatment earlier than was possible before. The showcase follows successful clinical evaluation of FXG:Resp (Asp+) and the CE marking of Myconostica’s efficient fungal DNA extraction kit (MycXtra) to European member countries.
